LUNG CANCERS ASSOCIATED WITH THOROTRAST EXPOSURE - HIGH-INCIDENCE OF SMALL-CELL CARCINOMA AND IMPLICATIONS FOR ESTIMATION OF RADON RISK

被引:9
|
作者
ISHIKAWA, Y
MORI, T
KATO, Y
TSUCHIYA, E
MACHINAMI, R
SUGANO, H
KITAGAWA, T
机构
[1] CANC INST,DEPT PATHOL,TOSHIMA KU,TOKYO 170,JAPAN
[2] NATL INST RADIOL SCI,CHIBA 260,JAPAN
[3] UNIV TOKYO,DEPT PATHOL,TOKYO 113,JAPAN
关键词
D O I
10.1002/ijc.2910520413
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The widely accepted concept that the alpha-emitting radionuclide radon (Rn-222, Rn-220) induces lung cancers in humans has been based on the excess of lung tumours observed in underground miners extracting uranium or other substances. However, this poses the important: question of whether radon is the only carcinogenic factor because such miners are also heavily exposed to mine dusts including silicates, diesel exhaust, etc. in their working environment. Patients to whom Thorotrast was administered continuously exhale radon (Rn-220) derived from Th-232 deposits in the body and therefore provide a good model for lung carcinogenesis by radon without concomitant dust exposure. We therefore investigated lung-cancer incidence in our epidemiological follow-up series, analysing the histological types of 11 lung cancers which were found among 359 Thorotrast autopsy cases and measuring radioactivity in the breath of living Thorotrast patients. The study revealed that, while the proportion of small-cell lung cancers considered to be related to alpha-particles was significantly increased, the overall lung cancer incidence was not significantly higher than in controls, in spite of the high level of Rn-220 in the patients' breath. This result suggests that radon in the lung does induce cancers (particularly small-cell carcinomas) but that the induction rate is not as high as expected from risk factors associated with mining. Thus, excess lung cancers among the miners might be related to the combined effects of exposure to radon and mine dusts, and not solely to radon.
引用
收藏
页码:570 / 574
页数:5
相关论文
共 50 条
  • [1] IMPLICATIONS OF NUCLEAR DIAMETER IN SMALL-CELL LUNG-CARCINOMA
    LEE, TK
    HORNER, RD
    SILVERMAN, JF
    JACKSON, DV
    ANDERSONGOETZ, D
    SCARANTINO, CW
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1990, 12 (02): : 78 - 84
  • [3] MYASTHENIA-GRAVIS ASSOCIATED WITH SMALL-CELL CARCINOMA OF THE LUNG
    FUJITA, J
    YAMADORI, I
    YAMAJI, Y
    YAMAGISHI, Y
    TAKIGAWA, K
    TAKAHARA, J
    CHEST, 1994, 105 (02) : 624 - 625
  • [4] Seropositive Myasthenia Gravis Associated with Small-Cell Lung Carcinoma
    Ohira, Masayuki
    Jeong, Dushin
    Oh, Shin J.
    JOURNAL OF CLINICAL NEUROLOGY, 2011, 7 (01): : 43 - 46
  • [5] BRONCHIAL EPITHELIAL CHANGES ASSOCIATED WITH SMALL-CELL CARCINOMA OF THE LUNG
    YONEDA, K
    BOUCHER, LD
    HUMAN PATHOLOGY, 1993, 24 (11) : 1180 - 1183
  • [6] HIGH-DOSE CYCLOPHOSPHAMIDE IN SMALL-CELL CARCINOMA OF THE LUNG
    SOUHAMI, RL
    FINN, G
    GREGORY, WM
    BIRKHEAD, BG
    BUCKMAN, R
    EDWARDS, D
    GOLDSTONE, AH
    HARPER, PG
    SPIRO, SG
    TOBIAS, JS
    GEDDES, D
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (07) : 958 - 963
  • [8] Panhypopituitarism revealing metastasis of small-cell lung carcinoma associated with sarcoidosis
    Bouaziz, H.
    Kaffel, N.
    Charfi, N.
    Fourati, M.
    Abid, H.
    Abid, M.
    ANNALES D ENDOCRINOLOGIE, 2006, 67 (03) : 259 - 264
  • [9] TUMOR-INDUCED HYPOPHOSPHATEMIA ASSOCIATED WITH SMALL-CELL CARCINOMA OF THE LUNG
    SINHA, AK
    DELUISE, M
    PIERCE, R
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1994, 24 (03): : 322 - 323
  • [10] Atezolizumab-associated Dermatomyositis in Advanced Small-cell Lung Carcinoma
    Yamaguchi, Yoshitaka
    Aso, Mari
    Nagasawa, Hikaru
    Wada, Manabu
    INTERNAL MEDICINE, 2021, 60 (18) : 3025 - 3029